AAAAAA

   
Results: 1-7 |
Results: 7
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Fox, NL Forman, S Hunninghake, DB Campeau, L Herd, JA Hoogwerf, BJ Hickey, A Probstfield, JL Terrin, ML
Citation: Jm. Walenga et al., The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment, J THROMB TH, 11(2), 2001, pp. 143-149
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial
Authors: White, CW Gobel, FL Campeau, L Knatterud, GL Forman, SA Forrester, JS Geller, NL Herd, JA Hickey, A Hoogwerf, BJ Hunninghake, DB Rosenberg, Y Terrin, ML
Citation: Cw. White et al., Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial, CIRCULATION, 104(22), 2001, pp. 2660-2665
Cost-effectiveness of hydroxyurea in sickle cell anemia
Authors: Moore, RD Charache, S Terrin, ML Barton, FB Ballas, SK
Citation: Rd. Moore et al., Cost-effectiveness of hydroxyurea in sickle cell anemia, AM J HEMAT, 64(1), 2000, pp. 26-31
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial
Authors: Knatterud, GL Rosenberg, Y Campeau, L Geller, NL Hunninghake, DB Forman, SA Forrester, JS Gobel, FL Herd, JA Hickey, A Hoogwerf, BJ Terrin, ML White, C
Citation: Gl. Knatterud et al., Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial, CIRCULATION, 102(2), 2000, pp. 157
Defining organ involvement in sarcoidosis: the ACCESS proposed instrument
Authors: Judson, MA Baughman, RP Teirstein, AS Terrin, ML Yeager, H
Citation: Ma. Judson et al., Defining organ involvement in sarcoidosis: the ACCESS proposed instrument, SARCO VASC, 16(1), 1999, pp. 75-86
Hemostatic effects of 1 mg daily warfarin on post CABG patients
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Cressman, MD Hunninghake, DB Fox, NL Terrin, ML Probstfield, JL
Citation: Jm. Walenga et al., Hemostatic effects of 1 mg daily warfarin on post CABG patients, J THROMB TH, 7(3), 1999, pp. 313-318
Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS)
Authors: Baughman, RP Bresnitz, E Iannuzzi, M McLennan, G Moller, D Musson, R Newman, LS Rabin, D Rossman, MD Teirstein, A Terrin, ML Thompson, BW
Citation: Rp. Baughman et al., Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS), J CLIN EPID, 52(12), 1999, pp. 1173-1186
Risultati: 1-7 |